Latvia - Antihypertensive Medicine Use

Since 2014, Latvia Antihypertensive Medicine Use increased 7.7% year on year. At 13.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 5 among other countries in Antihypertensive Medicine Use. Latvia is overtaken by Slovenia, which was number 4 with 14.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by United Kingdom with 13.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +4.2% versus 2018. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia witnessed the worst performance at -9.8% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 13.50
2018 12.00
2017 11.40
2016 10.40
2015 9.80
Download all data from 2012 to 2019

How does Latvia rank in Antihypertensive Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Hungary
35 2019 +4.2 % +4.2 % View data
2 #2
Lithuania
24 2019 +4.7 % -3.6 % View data
4 #4
Slovenia
15 2019 +0.7 % +0.0 % View data
5 #5
Latvia
14 2019 +12.5 % +7.7 % View data
6 #6
United Kingdom
13 2019 -0.7 % -0.7 % View data
Compare all 28 countries

Go Top